- Home
- TLYS vs MAIA Comparison
TLYS vs MAIA Comparison
Compare TLYS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLYS
- MAIA
- Stock Information
- Founded
- TLYS 1982
- MAIA 2018
- Country
- TLYS United States
- MAIA United States
- Employees
- TLYS N/A
- MAIA N/A
- Industry
- TLYS Clothing/Shoe/Accessory Stores
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- TLYS Consumer Discretionary
- MAIA Health Care
- Exchange
- TLYS Nasdaq
- MAIA Nasdaq
- Market Cap
- TLYS 53.7M
- MAIA 46.7M
- IPO Year
- TLYS 2012
- MAIA 2022
- Fundamental
- Price
- TLYS $1.45
- MAIA $1.88
- Analyst Decision
- TLYS Hold
- MAIA
- Analyst Count
- TLYS 2
- MAIA 0
- Target Price
- TLYS $2.25
- MAIA N/A
- AVG Volume (30 Days)
- TLYS 476.3K
- MAIA 536.7K
- Earning Date
- TLYS 09-04-2025
- MAIA 08-08-2025
- Dividend Yield
- TLYS N/A
- MAIA N/A
- EPS Growth
- TLYS N/A
- MAIA N/A
- EPS
- TLYS N/A
- MAIA N/A
- Revenue
- TLYS $561,208,000.00
- MAIA N/A
- Revenue This Year
- TLYS N/A
- MAIA N/A
- Revenue Next Year
- TLYS $3.22
- MAIA N/A
- P/E Ratio
- TLYS N/A
- MAIA N/A
- Revenue Growth
- TLYS N/A
- MAIA N/A
- 52 Week Low
- TLYS $0.57
- MAIA $1.40
- 52 Week High
- TLYS $6.28
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- TLYS 54.48
- MAIA 56.41
- Support Level
- TLYS $1.40
- MAIA $1.80
- Resistance Level
- TLYS $1.52
- MAIA $2.15
- Average True Range (ATR)
- TLYS 0.16
- MAIA 0.13
- MACD
- TLYS 0.01
- MAIA 0.02
- Stochastic Oscillator
- TLYS 46.48
- MAIA 60.00
About TLYS Tilly's Inc.
Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.